Article Sidebar
Published:
Jul 20, 2016Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
Titrated oral misoprostol solution- a new method of labour induction
Abstract
Background. Misoprostol, a cheap, stable, orally active prostaglandin analogue, is effective for labour induction when administered either vaginally or orally, but uterine hyperstimulation and rupture have been reported. Previous studies of oral misoprostol for labour induction have used fixed dosages 3 - 6-hourly.
Objectives. To develop a new method of misoprostol use for labour induction using very small, frequent, titrated oral dosages, and to pilot effectiveness.
Study design. Open clinical pilot study.
Setting. Coronation Hospital, an academic hospital in Johannesburg, South Africa.
Methods. We developed a method using 2-hourly titrated misoprostol doses commencing with 20 μg, increased after three doses to 40 μg. To administer such small doses we dissolved one rnisoprostol tablet in 200 ml water. A pilot study of this method was undertaken in 25 women with various indications for induction of labour.
Results. Eighteen women (72%) delivered vaginally within 32 hours of induction and two women developed uterine hyperstirnulation. The caesarean section rate was 20%.
Conclusions. Women may respond to much smaller dosages of misoprostol than are currently in use. A multicentre randomised trial of this method is underway. We emphasise the dangers inherent in the current unregistered use of misoprostol in clinical practice.
